P-108: An antisense platform for the pre-clinical development of novel LncRNA inhibitors in multiple myeloma
Clinical Lymphoma Myeloma and Leukemia(2022)
Key words
novel lncrna inhibitors,multiple myeloma,antisense platform,pre-clinical
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined